Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23688546 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
Condition: Influenza
Interventions: Biological: GSK Biologicals' quadrivalent influenza vaccine;   Biological: GSK Biologicals' trivalent influenza vaccine

Indicates status has not been verified in more than two years